Literature DB >> 172458

Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.

H Schmitz, D Kampa, W Heidenreich.   

Abstract

The anti-complement immunofluorescence (ACIF) test was modified to detect non-complement-fixing antibodies to Epstein-Barr (EB) virus nuclear antigen (IBNA). These EBNA antibodies belong to the immunoglobulin classes IgA and IgG. In our method anti-human gamma-globulin (AHG) was bound to the EBNA antibodies before the complement was added. If only non-complement-fixing antibodies are present the complement can be fixed to the AHG. Within only a few weeks of the onset of infectious mononucleosis (IM) the non-complement-fixing EBNA antibodies reach high titers while the complement-fixing antibodies (detected by the ACIF test) are not yet present. Anti-EBNA-IgM antibodies were not found in the IgM fractions of sera taken at different stages of IM.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172458     DOI: 10.1002/ijc.2910160617

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

2.  Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.

Authors:  M A Catalano; D A Carson; S F Slovin; D D Richman; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  IgM antibodies to cytomegalovirus during pregnancy.

Authors:  D Kampa; H Schmitz; H W Doerr; T Luthardt; H G Hillemanns; A Wurtele
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.